A UCLA-led study in collaboration with Harvard and Oxford University researchers has revealed a new way to predict which patients with "stable" heart failure - those who have heart injury but do not require hospitalisation - have a higher risk of dying within one to three years.
Although people with stable heart failure have similar characteristics, some have rapid disease progression while others remain stable. The research shows that patients who have higher levels of neuropeptide Y, a molecule released by the nervous system, are 10 times more likely to die within one to three years than those with lower levels of neuropeptides.
Read more (Department of Physiology, Anatomy & Genetics)